|
US659463A
(en)
|
1899-11-18 |
1900-10-09 |
E & A H Batcheller Company |
Heel-attaching machine.
|
|
US692988A
(en)
|
1901-05-20 |
1902-02-11 |
Seneca Falls Mfg Company |
Drill-chuck.
|
|
US2099402A
(en)
|
1934-01-17 |
1937-11-16 |
Pratt Food Company |
Pill or tablet
|
|
US2507631A
(en)
|
1944-01-19 |
1950-05-16 |
Ciba Pharm Prod Inc |
Pyridine and piperidine compounds and process of making same
|
|
US2957880A
(en)
|
1953-12-23 |
1960-10-25 |
Ciba Pharm Prod Inc |
Process for the conversion of stereoisomers
|
|
US2830933A
(en)
|
1955-07-14 |
1958-04-15 |
Pfizer & Co C |
Vitamin b12 products and preparation thereof
|
|
US2809918A
(en)
|
1955-10-17 |
1957-10-15 |
Victor M Hermelin |
Sustained release pharmaceutical preparations
|
|
US2990332A
(en)
|
1958-04-02 |
1961-06-27 |
Wallace & Tiernan Inc |
Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
|
|
US3048526A
(en)
|
1958-08-04 |
1962-08-07 |
Wander Company |
Medicinal tablet
|
|
US3146919A
(en)
|
1960-10-17 |
1964-09-01 |
Story F Chappell |
Ball follower dispenser
|
|
US3138525A
(en)
|
1961-06-16 |
1964-06-23 |
Hoffmann La Roche |
Castor wax-amprotropine-resin compositions
|
|
US3499960A
(en)
|
1965-01-25 |
1970-03-10 |
Merck & Co Inc |
Palatable coated particles of an anion exchange resin
|
|
US3365365A
(en)
|
1965-08-09 |
1968-01-23 |
Hoffmann La Roche |
Repeat action pharmaceutical compositions in the form of discrete beadlets
|
|
US3594470A
(en)
|
1968-02-19 |
1971-07-20 |
Abbott Lab |
Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
|
|
GB1218102A
(en)
|
1968-03-15 |
1971-01-06 |
Philips Nv |
Improvements in medicaments comprising drug/ion-exchange resin compounds
|
|
US3567079A
(en)
|
1968-08-08 |
1971-03-02 |
Cleone H Weigand |
Dispenser container with metering neck
|
|
LU63060A1
(enExample)
|
1971-04-26 |
1971-08-26 |
|
|
|
DE2246037B2
(de)
|
1972-09-20 |
1975-02-27 |
Taeschner & Co, 8831 Kipfenberg |
Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
|
|
DE2322883A1
(de)
|
1973-05-07 |
1974-11-28 |
Roehm Gmbh |
Wasserloesliche polymerisate
|
|
US4221778A
(en)
|
1979-01-08 |
1980-09-09 |
Pennwalt Corporation |
Prolonged release pharmaceutical preparations
|
|
US4363323A
(en)
|
1980-12-04 |
1982-12-14 |
Geiss Alan C |
Nasogastric tube adapted to avoid pressure necrosis
|
|
JPS5941574U
(ja)
|
1982-09-07 |
1984-03-17 |
三菱鉛筆株式会社 |
ボ−ルペン
|
|
CH655507B
(enExample)
*
|
1983-01-12 |
1986-04-30 |
|
|
|
US4459278A
(en)
|
1983-03-07 |
1984-07-10 |
Clear Lake Development Group |
Composition and method of immobilizing emetics and method of treating human beings with emetics
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4762709A
(en)
*
|
1983-09-16 |
1988-08-09 |
Pennwalt Corporation |
Liquid prolonged release pharmaceutical formulations containing ionic constituents
|
|
IE56999B1
(en)
|
1983-12-22 |
1992-03-11 |
Elan Corp Plc |
Pharmaceutical formulation
|
|
US4894240A
(en)
|
1983-12-22 |
1990-01-16 |
Elan Corporation Plc |
Controlled absorption diltiazem formulation for once-daily administration
|
|
US4876094A
(en)
*
|
1984-01-13 |
1989-10-24 |
Battelle Development Corporation |
Controlled release liquid dosage formulation
|
|
US4552899A
(en)
|
1984-04-09 |
1985-11-12 |
Analgesic Associates |
Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
|
|
US4847077A
(en)
|
1984-07-18 |
1989-07-11 |
Pennwalt Corporation |
Controlled release pharmaceutical preparations
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4600645A
(en)
|
1985-01-31 |
1986-07-15 |
Warner-Lambert Company |
Process for treating dosage forms
|
|
US4619673A
(en)
|
1985-05-15 |
1986-10-28 |
Multiform Desiccants, Inc. |
Adsorbent device
|
|
EP0227814A1
(en)
|
1985-07-02 |
1987-07-08 |
The Upjohn Company |
Therapeutic formulations with bimodal release characteristics
|
|
GB8518301D0
(en)
|
1985-07-19 |
1985-08-29 |
Fujisawa Pharmaceutical Co |
Hydrodynamically explosive systems
|
|
JPS62103012A
(ja)
|
1985-10-23 |
1987-05-13 |
Eisai Co Ltd |
多重顆粒
|
|
US4775536A
(en)
|
1986-02-24 |
1988-10-04 |
Bristol-Myers Company |
Enteric coated tablet and process for making
|
|
US4794001A
(en)
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
DE3617432A1
(de)
|
1986-05-23 |
1987-11-26 |
Standard Elektrik Lorenz Ag |
Elektronenstrahlerzeugungssystem
|
|
US4859461A
(en)
*
|
1986-07-30 |
1989-08-22 |
Fisons Corporation |
Coatable ion exchange resins
|
|
US4752470A
(en)
|
1986-11-24 |
1988-06-21 |
Mehta Atul M |
Controlled release indomethacin
|
|
GB2201395B
(en)
|
1986-12-17 |
1990-05-02 |
English Glass Co Ltd |
Liquid dosing device
|
|
US4910932A
(en)
|
1987-01-05 |
1990-03-27 |
Honigman Michael L |
Modular building system
|
|
US4894239A
(en)
|
1987-06-02 |
1990-01-16 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation and production thereof
|
|
US4808411A
(en)
|
1987-06-05 |
1989-02-28 |
Abbott Laboratories |
Antibiotic-polymer compositions
|
|
GB2206880B
(en)
|
1987-07-16 |
1991-04-24 |
Farmos Oy |
Optical isomers of an imidazole derivative
|
|
IL87710A
(en)
|
1987-09-18 |
1992-06-21 |
Ciba Geigy Ag |
Covered floating retard form for controlled release in gastric juice
|
|
IL90245A
(en)
|
1988-05-11 |
1994-04-12 |
Glaxo Group Ltd |
Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
|
|
US5219563A
(en)
*
|
1988-05-11 |
1993-06-15 |
Glaxo Group Limited |
Drug adsorbates
|
|
JPH01287270A
(ja)
|
1988-05-13 |
1989-11-17 |
Matsushita Electric Ind Co Ltd |
スパッタリング装置
|
|
JPH0217912A
(ja)
|
1988-07-06 |
1990-01-22 |
Matsushita Electric Ind Co Ltd |
空気清浄機
|
|
US5296236A
(en)
|
1988-09-16 |
1994-03-22 |
Recordati S.A., Chemical And Pharmaceutical Company |
Controlled release therapeutic system for a liquid pharmaceutical formulations
|
|
US4996047A
(en)
*
|
1988-11-02 |
1991-02-26 |
Richardson-Vicks, Inc. |
Sustained release drug-resin complexes
|
|
CA2002492A1
(en)
|
1988-11-11 |
1990-05-11 |
Sandra T. A. Malkowska |
Pharmaceutical ion exchange resin composition
|
|
US5186930A
(en)
|
1988-11-14 |
1993-02-16 |
Schering Corporation |
Sustained release oral suspensions
|
|
US4999189A
(en)
|
1988-11-14 |
1991-03-12 |
Schering Corporation |
Sustained release oral suspensions
|
|
US5275819A
(en)
|
1989-02-06 |
1994-01-04 |
Amer Particle Technologies Inc. |
Drug loaded pollen grains with an outer coating for pulsed delivery
|
|
GB2230442B
(en)
|
1989-02-16 |
1992-11-25 |
Nat Res Dev |
Controlled release device
|
|
JP3126127B2
(ja)
|
1989-04-28 |
2001-01-22 |
アジレント・テクノロジー株式会社 |
試験データ圧縮方式
|
|
NZ234143A
(en)
*
|
1989-06-28 |
1991-10-25 |
Mcneil Ppc Inc |
Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
|
|
US5158777A
(en)
|
1990-02-16 |
1992-10-27 |
E. R. Squibb & Sons, Inc. |
Captopril formulation providing increased duration of activity
|
|
US5156850A
(en)
|
1990-08-31 |
1992-10-20 |
Alza Corporation |
Dosage form for time-varying patterns of drug delivery
|
|
US5422121A
(en)
|
1990-11-14 |
1995-06-06 |
Rohm Gmbh |
Oral dosage unit form
|
|
US5275820A
(en)
|
1990-12-27 |
1994-01-04 |
Allergan, Inc. |
Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
|
|
US5431922A
(en)
*
|
1991-03-05 |
1995-07-11 |
Bristol-Myers Squibb Company |
Method for administration of buspirone
|
|
US5242428A
(en)
|
1991-10-04 |
1993-09-07 |
Aubrey Palestrant |
Apparatus for wetting hydrophilic-coated guide wires and catheters
|
|
US5286493A
(en)
*
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5273760A
(en)
*
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
|
NZ246748A
(en)
|
1991-12-27 |
1999-05-28 |
Kos Pharma Inc |
Migraine-preventing medicaments comprising a mast cell degranulation blocking agent (e.g. hydroxyzine, ketotifen, azatadine, azelastine, cyproheptadine, oxatomide, terfenadine, etc)
|
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5322073A
(en)
|
1992-01-30 |
1994-06-21 |
Sandoz Ltd. |
Feeding tube retaining strap
|
|
US5272137A
(en)
*
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
|
JP3207494B2
(ja)
|
1992-04-02 |
2001-09-10 |
ロート製薬株式会社 |
水性懸濁製剤
|
|
JP3278192B2
(ja)
|
1992-04-03 |
2002-04-30 |
ロート製薬株式会社 |
徐放性液剤
|
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
DE4319649A1
(de)
*
|
1993-03-18 |
1994-09-22 |
Asta Medica Ag |
Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
|
|
NZ260408A
(en)
*
|
1993-05-10 |
1996-05-28 |
Euro Celtique Sa |
Controlled release preparation comprising tramadol
|
|
JP2916978B2
(ja)
|
1993-08-25 |
1999-07-05 |
エスエス製薬株式会社 |
放出開始制御型製剤
|
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
|
MX9700850A
(es)
|
1995-06-09 |
1997-09-30 |
Euro Celtique Sa |
Formulaciones y metodos para proporcionar anestesia local prolongada.
|
|
GB9514451D0
(en)
|
1995-07-14 |
1995-09-13 |
Chiroscience Ltd |
Sustained-release formulation
|
|
ES2144264T3
(es)
*
|
1995-08-29 |
2000-06-01 |
Exxon Chemical Patents Inc |
Polipropileno tolerante a la radiacion y sus articulos utiles.
|
|
US6355656B1
(en)
|
1995-12-04 |
2002-03-12 |
Celgene Corporation |
Phenidate drug formulations having diminished abuse potential
|
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
|
US5908850A
(en)
|
1995-12-04 |
1999-06-01 |
Celgene Corporation |
Method of treating attention deficit disorders with d-threo methylphenidate
|
|
US6486177B2
(en)
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
|
JPH09323180A
(ja)
|
1996-06-04 |
1997-12-16 |
Asahi Optical Co Ltd |
スケーリング補正機能を持つレーザ描画装置
|
|
ES2262174T3
(es)
|
1996-09-30 |
2006-11-16 |
Alza Corporation |
Forma de dosificacion y procedimiento de administracion de medicamentos.
|
|
CN1179450A
(zh)
*
|
1996-10-15 |
1998-04-22 |
罗姆和哈斯公司 |
含有离子交换树脂的涂料组合物
|
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
US5900882A
(en)
|
1996-11-15 |
1999-05-04 |
Samsung Electronics Co., Ltd. |
Determining texture coordinates in computer graphics
|
|
ATE406872T1
(de)
|
1996-12-20 |
2008-09-15 |
Mcneil Ppc Inc |
Durch ionenaustauscherharze verabreichte hustenmittel
|
|
DE19709663A1
(de)
|
1997-03-10 |
1998-09-17 |
Basf Ag |
Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
|
|
DE19709532A1
(de)
*
|
1997-03-10 |
1998-09-17 |
Basf Ag |
Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
|
|
US5980882A
(en)
*
|
1997-04-16 |
1999-11-09 |
Medeva Pharmaceuticals Manufacturing |
Drug-resin complexes stabilized by chelating agents
|
|
GB9707934D0
(en)
*
|
1997-04-18 |
1997-06-04 |
Danbiosyst Uk |
Improved delivery of drugs to mucosal surfaces
|
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
DE19732903A1
(de)
*
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
|
EP1041988A4
(en)
*
|
1997-12-22 |
2002-03-13 |
Euro Celtique Sa |
METHOD FOR PREVENTING ABUSE OF OPIOID DOSES FORMS
|
|
EP0943341A1
(en)
|
1998-02-18 |
1999-09-22 |
Oscar Gold |
Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides
|
|
IT1304271B1
(it)
|
1998-03-17 |
2001-03-13 |
Tecno 5 S R L |
Gruppo serigrafico polifunzionale per macchine a giostra per la stampa serigrafica a piu' colori di contenitori con superfici curve.
|
|
US6905707B2
(en)
*
|
1998-05-28 |
2005-06-14 |
Medical Research Institute |
Controlled release arginine alpha ketoglutarate
|
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
CA2348871C
(en)
|
1998-11-02 |
2009-04-14 |
John G. Devane |
Multiparticulate modified release composition
|
|
US20070160675A1
(en)
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
|
US20060240105A1
(en)
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
|
EP1135150B1
(en)
*
|
1998-12-11 |
2012-10-17 |
Tris Pharma, Inc. |
Self-emulsifying compositions for drugs poorly soluble in water
|
|
US7083808B2
(en)
|
1998-12-17 |
2006-08-01 |
Euro-Celtique S.A. |
Controlled/modified release oral methylphenidate formulations
|
|
US6673367B1
(en)
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
|
US6419960B1
(en)
*
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
|
WO2000040224A1
(en)
*
|
1999-01-07 |
2000-07-13 |
Elan Corporation, Plc |
Multiparticulate oral dosage forms
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
WO2000059479A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
|
|
DE19927689A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
|
US6384020B1
(en)
|
1999-07-14 |
2002-05-07 |
Shire Laboratories, Inc. |
Rapid immediate release oral dosage form
|
|
WO2001008661A2
(en)
*
|
1999-07-29 |
2001-02-08 |
Roxane Laboratories, Inc. |
Opioid sustained-released formulation
|
|
DE19961897A1
(de)
*
|
1999-12-20 |
2001-06-28 |
Basf Ag |
Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
|
|
ATE312595T1
(de)
|
2000-01-19 |
2005-12-15 |
Mannkind Corp |
Formulierung mit mehrfach gepulster wirkstofffreisetzung
|
|
DE60138706D1
(de)
*
|
2000-02-08 |
2009-06-25 |
Euro Celtique Sa |
Missbrauchssichere orale opioid-agonist zubereitungen
|
|
US6322011B1
(en)
|
2000-03-14 |
2001-11-27 |
Illinois Tool Works Inc. |
Electrostatic coating system and dual lip bell cup therefor
|
|
US7067116B1
(en)
*
|
2000-03-23 |
2006-06-27 |
Warner-Lambert Company Llc |
Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
|
|
DE10015479A1
(de)
|
2000-03-29 |
2001-10-11 |
Basf Ag |
Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
|
|
SE0001151D0
(sv)
|
2000-03-31 |
2000-03-31 |
Amarin Dev Ab |
Method for producing a controlled-release composition
|
|
US6670058B2
(en)
*
|
2000-04-05 |
2003-12-30 |
University Of Central Florida |
Thermocatalytic process for CO2-free production of hydrogen and carbon from hydrocarbons
|
|
US6551617B1
(en)
*
|
2000-04-20 |
2003-04-22 |
Bristol-Myers Squibb Company |
Taste masking coating composition
|
|
US6419954B1
(en)
*
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
|
JP3380536B2
(ja)
|
2000-08-25 |
2003-02-24 |
日本圧着端子製造株式会社 |
圧接コネクタの受取装置及びこれを備えた自動圧接機
|
|
IL145106A0
(en)
*
|
2000-08-30 |
2002-06-30 |
Pfizer Prod Inc |
Intermittent administration of a geowth hormone secretagogue
|
|
US6344215B1
(en)
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
|
GB0030460D0
(en)
|
2000-12-14 |
2001-01-24 |
Isis Innovation |
Drug delivery system
|
|
DE10108122A1
(de)
*
|
2001-02-21 |
2002-10-02 |
Gruenenthal Gmbh |
Arzneimittel auf Basis von Tramadol
|
|
DE60212475T2
(de)
*
|
2001-03-14 |
2007-07-05 |
Pfizer Products Inc., Groton |
Pharmazeutische Tablette und ein Verfahren zu ihrer Herstellung
|
|
EP1250937B1
(en)
*
|
2001-04-09 |
2009-05-13 |
Rohm And Haas Company |
Controlled dissolution of active ingredients
|
|
WO2002092059A1
(en)
*
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
|
EP1277896A1
(en)
|
2001-07-16 |
2003-01-22 |
Ulf Palmberg |
Floorboards
|
|
US7144587B2
(en)
*
|
2001-08-06 |
2006-12-05 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
|
|
EP1429728A1
(en)
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Sustained release preparations
|
|
WO2003025520A1
(en)
|
2001-09-12 |
2003-03-27 |
Anthony Charles Lammond Wass |
Improved liquid dosing device
|
|
ES2392960T3
(es)
*
|
2001-10-17 |
2012-12-17 |
Takeda Pharmaceutical Company Limited |
Gránulos que contienen gran cantidad de compuesto químico inestable en medio ácido
|
|
US20040126428A1
(en)
*
|
2001-11-02 |
2004-07-01 |
Lyn Hughes |
Pharmaceutical formulation including a resinate and an aversive agent
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
DE10211289A1
(de)
*
|
2002-03-14 |
2003-09-25 |
Basf Ag |
Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
|
|
EP1492511B3
(fr)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
|
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
|
US6939029B1
(en)
*
|
2002-05-28 |
2005-09-06 |
Kuryakyn Holdings, Inc. |
Modular light assembly for decorative lights
|
|
DE60330780D1
(de)
|
2002-06-05 |
2010-02-11 |
Opexa Pharmaceuticals Inc |
Sequenzen des t-zellrezeptors cdr3 und nachweisverfahren
|
|
JP2006504651A
(ja)
|
2002-07-16 |
2006-02-09 |
アミュラ テラピューティクス リミテッド |
生物活性化合物
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
US8216609B2
(en)
*
|
2002-08-05 |
2012-07-10 |
Torrent Pharmaceuticals Limited |
Modified release composition of highly soluble drugs
|
|
US20060240128A1
(en)
|
2002-09-09 |
2006-10-26 |
Schlagheck Thomas G |
Combined immediate release and extended release analgesic composition
|
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
AU2002342579A1
(en)
|
2002-09-24 |
2004-04-19 |
Gumlink A/S |
Chewing gum having improved release of chewing gum ingredients
|
|
US20060018972A1
(en)
*
|
2002-11-26 |
2006-01-26 |
Upm Pharmaceuticals, Inc. |
Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
|
|
JP4808405B2
(ja)
|
2002-11-26 |
2011-11-02 |
ホ−レンベック ギャリ− ア−ル |
高度に水溶性の電解質薬剤のための水性徐放性ドラッグデリバリーシステム
|
|
FR2848564B1
(fr)
*
|
2002-12-13 |
2006-12-01 |
Inst Rech Developpement Ird |
Souches bacteriennes du genre exiguobacterium, procede de culture et applications
|
|
CA2511540A1
(en)
*
|
2002-12-23 |
2004-07-22 |
Celltech Americas, Inc. |
Acid labile drug compositions
|
|
JP2006515320A
(ja)
*
|
2002-12-31 |
2006-05-25 |
ラリー エル オーグスバーガー |
活性クッション性成分を含有する医薬品剤形の製造方法
|
|
US6780126B2
(en)
*
|
2003-01-02 |
2004-08-24 |
Acushnet Company |
Golf ball with large inner core
|
|
US20040228830A1
(en)
|
2003-01-28 |
2004-11-18 |
Collegium Pharmaceutical, Inc. |
Multiparticulate compositions of milnacipran for oral administration
|
|
CH712083B1
(de)
|
2003-02-05 |
2017-07-31 |
Siegfried Ag |
Verfahren zur Herstellung von d-threo-2-Phenyl-2-piperidin-2-yl-essigsäureestern.
|
|
DE602004008771T2
(de)
|
2003-02-10 |
2008-06-12 |
Shire Canada Inc., St. Laurent |
Enantiomere amphetamine enthaltende zusammensetzungen zur behandlung von aufmerksamkeitsdefizit-/hyperaktivitätsstörung (adhd)
|
|
AU2004238321B2
(en)
*
|
2003-05-07 |
2009-08-27 |
Samyang Biopharmaceuticals Corporation |
Highly plastic granules for making fast melting tablets
|
|
US20060115529A1
(en)
*
|
2003-05-07 |
2006-06-01 |
Seonghoon Jeong |
Fast-melting tablets having taste-masking and sustained release properties
|
|
US6997219B2
(en)
|
2003-05-12 |
2006-02-14 |
Medical Instill Technologies, Inc. |
Dispenser and apparatus and method for filling a dispenser
|
|
US20040259809A1
(en)
|
2003-06-17 |
2004-12-23 |
Pediamed Pharmaceuticals, Inc. |
Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof
|
|
US20050036977A1
(en)
*
|
2003-08-11 |
2005-02-17 |
Dilip Gole |
Taste-masked resinate and preparation thereof
|
|
CN1845722A
(zh)
*
|
2003-09-03 |
2006-10-11 |
马林克罗特公司 |
粒状缓释制剂及其生产
|
|
MXPA06003725A
(es)
|
2003-10-08 |
2006-06-23 |
Mallinckrodt Inc |
Solucion de fenidato de metilo y metodos asociados de administracion y produccion.
|
|
US20050220881A1
(en)
|
2003-10-10 |
2005-10-06 |
Bvm Holding Co. |
Pharmaceutical composition
|
|
US20060029664A1
(en)
*
|
2004-08-04 |
2006-02-09 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing carbetapentane and another drug
|
|
US20050232986A1
(en)
*
|
2003-12-17 |
2005-10-20 |
David Brown |
Dosage form containing promethazine and another drug
|
|
US20050232987A1
(en)
*
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
US9492541B2
(en)
*
|
2004-09-14 |
2016-11-15 |
Sovereign Pharmaceuticals, Llc |
Phenylepherine containing dosage form
|
|
US20050142097A1
(en)
|
2003-12-29 |
2005-06-30 |
Deepak Thassu |
Multiple active drug resin conjugate
|
|
US20050181050A1
(en)
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
JP2005306778A
(ja)
|
2004-04-21 |
2005-11-04 |
Basf Ag |
徐放性製剤及びその製造方法
|
|
US20050266031A1
(en)
|
2004-05-25 |
2005-12-01 |
Jay Dickerson |
Pharmaceutical suspension composition
|
|
US20050265955A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
US9592197B2
(en)
*
|
2004-12-16 |
2017-03-14 |
Sovereign Pharmaceuticals, Llc |
Dosage form containing diphenhydramine and another drug
|
|
WO2006022996A2
(en)
|
2004-08-04 |
2006-03-02 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
|
DK1791530T3
(da)
|
2004-08-23 |
2008-10-27 |
Pejo Iserlohn Heilmittel Und D |
Farmaceutisk komposition indeholdende et psykostimulerende middel
|
|
EP1809259B1
(en)
|
2004-10-15 |
2014-12-03 |
Supernus Pharmaceuticals, Inc. |
Less abusable pharmaceutical preparations
|
|
US7173497B1
(en)
*
|
2004-11-05 |
2007-02-06 |
Rockwell Collins, Inc. |
Sampling voltage controlled oscillator
|
|
US20080095842A1
(en)
|
2004-12-06 |
2008-04-24 |
Antarkar Amit K |
Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
US7276794B2
(en)
|
2005-03-02 |
2007-10-02 |
Endevco Corporation |
Junction-isolated vias
|
|
EP1893175A1
(en)
|
2005-06-09 |
2008-03-05 |
Upm Pharmaceuticals, Inc. |
Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
|
|
JP2008546835A
(ja)
|
2005-06-28 |
2008-12-25 |
ユ セ ベ ソシエテ アノニム |
複数の活性薬物−樹脂抱合体
|
|
BRPI0613070A2
(pt)
|
2005-06-29 |
2010-12-21 |
Panacea Biotec Ltd |
composições farmacêuticas de liberação sustentada e seus processos
|
|
US8343546B2
(en)
|
2005-09-13 |
2013-01-01 |
Coating Place, Inc. |
Ion exchange resin treated to control swelling
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
US20070092553A1
(en)
|
2005-10-21 |
2007-04-26 |
Pfab Lp |
Compositions and methods of making rapidly dissolving lonically masked formulations
|
|
WO2007100777A2
(en)
|
2006-02-28 |
2007-09-07 |
The Mclean Hospital Corporation |
Methods for the treatment of adhd and related disorders
|
|
CA2645855C
(en)
|
2006-03-16 |
2015-02-03 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
US20080064694A1
(en)
|
2006-09-11 |
2008-03-13 |
Auriga Laboratories, Inc. |
Multi-Phase Release Methscopolamine Compositions
|
|
US8287848B2
(en)
|
2006-10-03 |
2012-10-16 |
Tris Pharma Inc |
Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
|
|
US20080118570A1
(en)
|
2006-11-20 |
2008-05-22 |
Zhi Liu |
Polymer coated drug-ion exchange resins and methods
|
|
WO2008064192A2
(en)
|
2006-11-21 |
2008-05-29 |
Mcneil-Ppc, Inc. |
Modified release analgesic suspensions
|
|
ES2364865T3
(es)
|
2006-12-11 |
2011-09-15 |
Kempharm, Inc. |
Conjugados de ornitina de la anfetamina y procedimientos de fabricación y de utilización de los mismos.
|
|
US20100104621A1
(en)
|
2007-02-21 |
2010-04-29 |
Connected Health Systems, Llc |
Treating adhd and other diseases involving inflammation
|
|
US8313770B2
(en)
|
2007-05-30 |
2012-11-20 |
Neos Therapeutics, Lp |
Modifying drug release in suspensions of ionic resin systems
|
|
US8202542B1
(en)
|
2007-05-31 |
2012-06-19 |
Tris Pharma |
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
|
|
JP5279246B2
(ja)
|
2007-12-05 |
2013-09-04 |
京セラドキュメントソリューションズ株式会社 |
画像形成装置および印刷システム
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
WO2010080787A1
(en)
|
2009-01-09 |
2010-07-15 |
Mallinckrodt Inc. |
Synthesis of methylphenidate and analogs thereof
|
|
EP3311667A1
(en)
|
2009-07-08 |
2018-04-25 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
US8470375B1
(en)
|
2010-01-05 |
2013-06-25 |
Neos Therapeutics, Lp |
Method of formulating and designing liquid drug suspensions containing ion exchange resin particles
|
|
GB201002612D0
(en)
|
2010-02-16 |
2010-03-31 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
|
EP2549986B1
(en)
|
2010-03-24 |
2019-10-30 |
Northeastern University |
Multi-compartmental macrophage delivery
|
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
|
US8287903B2
(en)
|
2011-02-15 |
2012-10-16 |
Tris Pharma Inc |
Orally effective methylphenidate extended release powder and aqueous suspension product
|
|
EP2675438B1
(en)
|
2011-02-15 |
2019-04-10 |
Tris Pharma, Inc. |
Extended release powder and aqueous suspension comprising methylphenidate
|
|
EP2726066B1
(en)
|
2011-06-28 |
2021-03-31 |
Neos Therapeutics, LP |
Dosage forms of amphetamine for oral administration
|
|
US20140214431A1
(en)
|
2011-07-01 |
2014-07-31 |
Dolby Laboratories Licensing Corporation |
Sample rate scalable lossless audio coding
|
|
CA2758556A1
(en)
|
2011-11-17 |
2013-05-17 |
Pharmascience Inc. |
Pharmaceutical composition of amphetamine mixed salts
|
|
DK2884961T3
(en)
|
2012-08-15 |
2019-04-23 |
Tris Pharma Inc |
METHYLPHENIDATE TABLE WITH EXTENDED RELEASE
|
|
WO2014058742A1
(en)
|
2012-10-09 |
2014-04-17 |
Sears Douglas |
Therapeutic treatment
|
|
US9180104B2
(en)
|
2013-03-13 |
2015-11-10 |
Tris Pharma, Inc. |
Benzonatate modified release solid tablets and capsules
|